Episode 42: Nextech's Thilo Schroeder
From BioVenture VoiCes with Chris Garabedian · · 1 hr 5 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.
Back to BioVenture VoiCes with Chris Garabedian · Report a problem